enGene Therapeutics Inc
enGene Therapeutics Inc (ENGN) Options Open Interest
ENGN options open interest is 9,468 contracts. The 2-week average daily volume is 252 contracts across the chain.
Read more
Monitoring ENGN open interest helps you see where real money is positioned on enGene Therapeutics Inc's options and which strikes are attracting the most commitment from traders. enGene Therapeutics Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor ENGN options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising ENGN options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect enGene Therapeutics Inc to settle.
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where ENGN open interest is concentrated. Our scanner maps enGene Therapeutics Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade enGene Therapeutics Inc's options open interest as the signal it is, not as an afterthought.
| 2.00 | 0.10 | 0.35 | 0.23 | 96% | +0.5924 | 337 |
| 1.00 | — | 4.10 | 4.10 | 1,000% | +0.9402 | 100 |
| 3.00 | — | 0.10 | 0.10 | 163% | +0.2411 | 70 |
| 2.00 | — | 0.25 | 0.25 | 135% | -0.4007 | 59 |
| 1.00 | — | 0.05 | 0.05 | 240% | -0.0691 | 0 |
| 3.00 | — | 3.90 | 3.90 | 1,000% | -0.1302 | 0 |
As of September 22, 2026
Follow the money
Track ENGN open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.
Start your 14-day free trial→